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HUMAN IMMUNODEFICIENCY VIRUS: Cellular Interactions 
by 
Juliet Carson 
Acquired Immunodeficiency Syndrome (AIDS) is a viral disease that has assumed epidemic 
proportions in the last ten years. Since 1981, when the Centers for Disease Control first alerted 
the medical community of this then mysterious outbreak of bizarre and usually fatal infections 
in homosexual men, the incidence of AIDS has doubled every year. (1) 
Scientists studying the phenomena identified a deficiency in the immune system (hence the 
name). The diagnostic features of AIDS are the appearance of one or both of two opportunistic 
infections in an individual who possesses antibodies to the human immunodeficiency virus (such 
an individual is referred to as seropositive). These infections are Kaposi's sarcoma, andPneumocystis 
carinii. The evidence of obvious HIV-induced illness in a seropositive individual without either 
Kaposi's sarcoma or Pneumocystis carinii is known as AIDS-related complex, (ARC). Symptoms 
of ARC are weight loss, oral thrush, and lymphadenopathy (2), a disease of the lymph nodes. 
Around 10 percent of ARC patients eventually develop AIDS. (1) 
The cause of the immunological paralysis associated with AIDS is the virtual debilitation of 
a specific part of the immune system. The different lymphocytes (commonly known as white 
blood cells) that compose the circulating portion of the immune system are divided into two 
groups, namely the B (or bursa-derived) lymphocytes and the T (or thymus-derived) lympho-
cytes. The B lymphocytes, or B cells, are responsible for humoral immune responses that are 
mediated by antibodies, and the T cells are responsible for cell-mediated immune responses. In 
a cell-mediated immune response, the T cells interact with antigens (foreign invaders into the 
body) on the surfaces of other cells. T cells are responsible for identifying and eliminating 
antigens in nearly all immune reactions. Regardless of the nature of the particular antigen-
fungus, virus, bacterium or an infected host cell whose surface has been altered by a foreign 
substance such as a virus-the T cell must locate and destroy it. 
In a cell-mediated immune response, after the T cells encounter antigens, they multiply and 
differentiate to become activated T cells. When the cells are involved in antigen-dependent 
differentiation, they activate into effector cells, such as cytotoxic (killer) T cells that are responsible 
for the lysis, <?r breakdown, of foreign cells; suppressor T cells that suppress immune response; and 
helper T cells, which secrete a substance called lymphokine that signals other T cells to 
differentiate and multiply. Because of their role of magnifying immune responses, helper T cells 
make up a crucial element in effective immune function. This paper deals primarily with helper 
Tcells. 
As stated above, the helperT cells are responsible for stimulating increased proliferation and 
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differentiation of other T cells. Therefore, after an antigen binds to a cell that possesses 
complementary surface receptors, the cell proliferates and differentiates into the various effector 
cells. After the initial immune response, the _helper T cells are responsible for ensuring that the 
other effector cells continue to be present until the antigen is thoroughly eliminated. If the helper 
T cells are absent, then the immune response cannot proceed to completion, and the body is in 
danger of being overcome by the pathogen, or disease-causing agent. (1) 
This paper examines the early interaction and infection of HIV into the helper T cells, the 
effects this has on the cell itself, and on some of the factors that influence this interaction. The data 
used here are based without exception on studies whose subjects were male individuals. 
The HIV itself is enclosed in a lipid bilayer envelope that is studded with glycoproteins gp41 
and gp120. (3a) This covers a matrix protein (pl 7) which in turn covers a cone-shaped core that 
houses the viral ribonucleoprotein containing the genetic information of the virus. (3b) The CD4 
antigen serves as the cell surface receptor for HIV on monocytes, lymphocytes, and other cells 
(3c-e), which means that HIV can attach itself to the surface of the CD4 cells because of 
complementarity. When the virus encounters and attaches to a CD4 cell, gp41 (glycoprotein) 
mediates the fusion of the virus with the cell membrane. Grewe, Beck and Gelderblom reported 
that absorption, a second mode of entry, took place two minutes after exposing the cell to the virus 
at 4 degrees Celsius in vitro, and entry took place from one to three minutes later at 37 degrees 
Celsius. Absorption was carried out via clathrin-coated pits on the cell surface and vesicle 
formation. The vesicles then fused with the endosomal membranes for endocytosis. Endocytosis 
is not discussed further in any of the literature I found. Endocytosis takes more time than fusion, 
even though they both start after one to three minutes. 
Fusion begins between the outer cellular membrane and the outer viral envelope at the 
specific attachment site. First the inner leaflet of the viral envelope and the inner lipid bilayer fuse, 
then either a seamless continuity between the two is established, or a rupture can occur at the 
fusion site. Penetration of the conical core of the virus follows formation of an opening-analogous 
to a silent, devastating rape. The core disintegrates and releases the viral ribonucleoprotein 
(RNP) into the cell. This is followed by vacuolization and cytolysis. The glycoproteins of HIV are 
incorporated into the cell membrane, which may be one explanation for the syncytia formation 
that commonly follows. At this point the CD4 cell has been taken over by the viral RNP, which has 
"written" its own sequences into the DNA of the cell by reverse transcriptase. The cell ceases to 
perform its previous function, and begins to manufacture new viruses. Eventually the cell bursts, 
releasing a multitude of new HIV into the system. (3) 
The symptoms of AIDS usually do not appear soon after infection. As a matter of fact, the HIV-
seropositive individual may be healthy for anywhere from two to five years after exposure to the 
virus. With such devastating effects on the helperTcells, this long incubation period is mysterious 
33 
to many scientists. It has been found that in vivo, HIV replication takes place only in activated T 
cells (as opposed to resting T cells) (4), and this may be associated with some of the delay. It has 
been suggested as well that adaptive immunity may influence the rate of virus replication and cell 
damage, (5a) so that the actual debilitation of the immune system is achieved over a long period 
of time because the immune system is equipped to withstand the effects of HIV for a time, but not 
indefinitely. One of the adaptive responses is a rise in CDS cells. This has been found to 
correspond to a lowered CD4 level in vivo. CDS cells produce a diffusible lymphokine whose 
presence drastically lowers the reverse transcriptase activity, so it interferes directly with virus 
replication. (6) This is, of course, extremely positive for the HIV-infected individual, while this 
defense continues in its ability to maintain a high level of activity. 
These are some proposed immune adaptations to the presence of HIV in the body. Unfortu-
nately, after infection the virus insidiously works in the immune system, and the infected 
individual mounts an immune response, causing HIV antibodies to circulate in the system. At this 
point, the patient is considered seropositive. In men who develop HIV antigenemia (the appear-
ance of HIV antigen that is detectable in serum or plasma) there is a highly increased chance of 
developing AIDS or ARC. The antigenemia is associated with lowered frequency of CD4 cells, and 
a lower presence of HIV antibodies. This stage precedes the development of AIDS or ARC 
symptoms. Patients who experience a transient or no antigenemia continue without symp-
toms. (2) I did not find accounts of people who were indefinitely asymptomatic, although the 
factors which determined the CDS activity (6) and the presence or absence of antigenemia (2) are 
not known. 
Because of the relative newness of HIV as an object of study, the body of information is 
constantly changing, and "old" theories about it are becoming obsolete as new information comes 
to light. Some areas that are lacking in information are the different entrance schemes (fusion and 
endocytosis), and what each determines in the process of infection; the relation of CDS cells and 
their unique lymphokine to HIV and the reverse transcriptase activity; also any possible 
connections between CDS cells and the development of antigenemia. The CDS-produced 
lymphokine and the CD4-produced lymphokine might be studied for their therapeutic possibili-
ties. 
As the study of AIDS progresses, so does its incidence in the human population: for every 
AIDS case in the United States and other epidemic areas, it is estimated thatthere are another fifty 
HIV-seropositive individuals without AIDS. (5b) The devastation that these individuals will 
probably endure is mirrored in a bizarre fashion in the cellular interactions of HIV. The ravages 
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